抗苗勒管激素与晚期生殖年龄的即将绝经:全国女性健康研究
该前瞻性纵向队列研究在1537名平均年龄47.5±2.6岁的绝经前或早期围绝经期女性中,评估抗苗勒管激素(AMH)预测最终月经(FMP)时间的能力。基于AMH的模型预测24个月内发生FMP的AUC显著大于基于FSH的模型。AMH<10 pg/mL的女性12个月内发生FMP的概率从<48岁的51%到≥51岁的79%;AMH>100 pg/mL的女性12个月内不发生FMP的概率从<48岁的97%到≥51岁的90%。结论认为AMH测量有助于估计FMP时间,且总体上优于FSH。
要点
- AMH预测24个月内发生FMP的AUC显著大于FSH。
- AMH<10 pg/mL者12个月内FMP概率<48岁为51%,≥51岁为79%。
- AMH>100 pg/mL者12个月内不发生FMP概率<48岁为97%,≥51岁为90%。
核心结论
- AMH测量有助于估计女性发生FMP的时间,且总体上优于FSH。
研究设计与样本
- 前瞻性纵向队列研究,来自全国女性健康研究(The Study of Women's Health Across the Nation)。
- 纳入1537名绝经前或早期围绝经期女性,基线平均年龄47.5±2.6岁,连续随访至出现12个月闭经。
- AMH采用双位点ELISA测定,检测下限为1.85 pg/mL。
主要发现
- 基于AMH的模型预测24个月内发生FMP的AUC显著大于基于FSH的模型。
- AMH<10 pg/mL的女性12个月内发生FMP的概率从<48岁的51%到≥51岁的79%。
- AMH>100 pg/mL的女性12个月内不发生FMP的概率从<48岁的97%到≥51岁的90%。
关键数值与推荐
- AMH<10 pg/mL者12个月内FMP概率:<48岁为51%,≥51岁为79%。
- AMH>100 pg/mL者12个月内不发生FMP概率:<48岁为97%,≥51岁为90%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A test that helps predict the time to the final menstrual period (FMP) has been sought for many years. OBJECTIVE: To assess the ability of antimullerian hormone (AMH) measurements to predictions the time to FMP. DESIGN: Prospective longitudinal cohort study. SETTING: The Study of Women's Health Across the Nation. PARTICIPANTS AND MEASUREMENTS: AMH and FSH were measured in 1537 pre- or early perimenopausal women, mean age 47.5 ± 2.6 years at baseline, then serially until 12 months of amenorrhea occurred. AMH was measured using a 2-site ELISA with a detection limit of 1.85 pg/mL. MAIN OUTCOME MEASURE: Areas under the receiver operating curves (AUC) for AMH-based and FSH-based predictions of time to FMP, stratified by age. Probabilities that women would undergo their FMP in the next 12, 24, or 36 months across a range of AMH values were assessed. RESULTS: AUCs for predicting that the FMP will occur within the next 24 months were significantly greater for AMH-based than FSH-based models. The probability that a woman with an AMH <10 pg/mL would undergo her FMP within the next 12 months ranged from 51% at h<48 years of age to 79% at ≥51 years. The probability that a woman with an AMH >100 pg/mL would not undergo her FMP within the next 12 months ranged from 97% in women <48 years old to 90% in women ≥51 years old. CONCLUSIONS: AMH measurement helps estimate when a woman will undergo her FMP, and, in general, does so better than FSH.
引用
- Finkelstein JS, Lee H, Karlamangla A, et al. Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2020. PMID: 31965189. doi:10.1210/clinem/dgz283
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。